Inhibiting intracellular signalling as a strategy for cancer chemoprevention

G. Powis, David S Alberts

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The intracellular signalling pathways that mediate the effects of growth factors and oncogenes on cell growth and transformation offer potential targets for the development of chemopreventive agents that prevent the progression of premalignant cells to invasive cancer. Agents acting on signalling targets would be expected to be cytostatic rather than cytotoxic agents. A number of existing chemopreventive agents exhibit, among their properties, inhibition of intracellular signalling enzymes. It is possible that this activity accounts, at least in part, for their chemopreventive properties.

Original languageEnglish (US)
Pages (from-to)1138-1144
Number of pages7
JournalEuropean Journal of Cancer
Volume30
Issue number8
DOIs
StatePublished - 1994

Fingerprint

Chemoprevention
Cytotoxins
Cytostatic Agents
Oncogenes
Neoplasms
Intercellular Signaling Peptides and Proteins
Enzymes
Growth

Keywords

  • chemoprevention
  • growth factors
  • intracellular signalling
  • oncogenes

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Inhibiting intracellular signalling as a strategy for cancer chemoprevention. / Powis, G.; Alberts, David S.

In: European Journal of Cancer, Vol. 30, No. 8, 1994, p. 1138-1144.

Research output: Contribution to journalArticle

@article{7e08cee17f894b33a9c714894aeb1cdf,
title = "Inhibiting intracellular signalling as a strategy for cancer chemoprevention",
abstract = "The intracellular signalling pathways that mediate the effects of growth factors and oncogenes on cell growth and transformation offer potential targets for the development of chemopreventive agents that prevent the progression of premalignant cells to invasive cancer. Agents acting on signalling targets would be expected to be cytostatic rather than cytotoxic agents. A number of existing chemopreventive agents exhibit, among their properties, inhibition of intracellular signalling enzymes. It is possible that this activity accounts, at least in part, for their chemopreventive properties.",
keywords = "chemoprevention, growth factors, intracellular signalling, oncogenes",
author = "G. Powis and Alberts, {David S}",
year = "1994",
doi = "10.1016/0959-8049(94)90473-1",
language = "English (US)",
volume = "30",
pages = "1138--1144",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - Inhibiting intracellular signalling as a strategy for cancer chemoprevention

AU - Powis, G.

AU - Alberts, David S

PY - 1994

Y1 - 1994

N2 - The intracellular signalling pathways that mediate the effects of growth factors and oncogenes on cell growth and transformation offer potential targets for the development of chemopreventive agents that prevent the progression of premalignant cells to invasive cancer. Agents acting on signalling targets would be expected to be cytostatic rather than cytotoxic agents. A number of existing chemopreventive agents exhibit, among their properties, inhibition of intracellular signalling enzymes. It is possible that this activity accounts, at least in part, for their chemopreventive properties.

AB - The intracellular signalling pathways that mediate the effects of growth factors and oncogenes on cell growth and transformation offer potential targets for the development of chemopreventive agents that prevent the progression of premalignant cells to invasive cancer. Agents acting on signalling targets would be expected to be cytostatic rather than cytotoxic agents. A number of existing chemopreventive agents exhibit, among their properties, inhibition of intracellular signalling enzymes. It is possible that this activity accounts, at least in part, for their chemopreventive properties.

KW - chemoprevention

KW - growth factors

KW - intracellular signalling

KW - oncogenes

UR - http://www.scopus.com/inward/record.url?scp=0027981240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027981240&partnerID=8YFLogxK

U2 - 10.1016/0959-8049(94)90473-1

DO - 10.1016/0959-8049(94)90473-1

M3 - Article

VL - 30

SP - 1138

EP - 1144

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 8

ER -